Seer Investor Relations Material

Seer, Inc. is a biotechnology company. It is engaged in the development and commercialization of products to decode the secret of the proteome. The company develops Proteograph Product Suite that enables researchers to understand and accelerate the progress of disease states. Seer, Inc. offers consumables, an automation instrumentation, and software components that are used in various proteomic studies such as drug discovery, clinical trials and other research applications. Its consumables are marketed under Proteograph brand name. Its automation instrumentation is marketed under ProteoLab brand name. It has collaboration agreements with life sciences organizations to offer its swab-free technology platform ParaGraph